Lenvatinib plus PD-1 inhibitors with transarterial embolization and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a bias-adjusted survival and clinical trajectory analysis

Lixin Du, Yang Zhang, Weiwei Lv, Hui Zhang, Tiezhong Zhang, Kangshuai Li, Qiangbo Zhang, Ben Wang, Dong Sun, Chunxiao Hu, Runde Jiang, Chuanzong Zhao, Hao Chen, Yi Liu, Yunfei Xu, Guangzhen Li, Sen Guo, Zongli Zhang